for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Teladoc Health Inc

TDOC.N

Latest Trade

109.61USD

Change

3.61(+3.41%)

Volume

803,366

Today's Range

109.06

 - 

119.97

52 Week Range

100.65

 - 

308.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
106.00
Open
117.24
Volume
803,366
3M AVG Volume
61.22
Today's High
119.97
Today's Low
109.06
52 Week High
308.00
52 Week Low
100.65
Shares Out (MIL)
160.09
Market Cap (MIL)
17,547.10
Forward P/E
-33.58
Dividend (Yield %)
--

Next Event

Q4 2021 Teladoc Health Inc Earnings Release

Latest Developments

More

Teladoc Health Q3 Loss Per Share $0.53

Teladoc Health Inc Reaffirms Its Q3 And FY 2021 Outlook

Teladoc Health Raises Full-Year Revenue Guidance

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Teladoc Health Inc

Teladoc Health, Inc. provides virtual healthcare services. The Company provides virtual access to care with a portfolio of services and solutions, which includes various medical subspecialties from non-urgent, episodic needs, such as flu and upper respiratory infections, to chronic, complicated medical conditions, such as hypertension, cancer and congestive heart failure. It provides provide virtual healthcare services on a business-to-business (B2B) basis to its clients including employers, health plans, hospitals and health systems, and insurance and financial services companies spanning the global healthcare landscape and provide services to consumers directly and through channel partners. The Company’s consumer brands, including Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp and HealthiestYou, provides access to advice and resolution for an array of healthcare needs.

Industry

Healthcare Facilities

Contact Info

2 Manhattanville Rd Ste 203

PURCHASE, NY

10577-2118

United States

+1.203.6352002

https://teladochealth.com/

Executive Leadership

David B. Snow

Independent Chairman of the Board

Jason N. Gorevic

Chief Executive Officer, Director

Mala Murthy

Chief Financial Officer

Arnnon Geshuri

Chief Human Resource Officer

Richard J. Napolitano

Senior Vice President, Chief Accounting Officer

Key Stats

2.28 mean rating - 29 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.4K

2019

0.6K

2020

1.1K

2021(E)

2.0K
EPS (USD)

2018

-1.470

2019

-1.380

2020

-5.360

2021(E)

-3.160
Price To Earnings (TTM)
--
Price To Sales (TTM)
9.42
Price To Book (MRQ)
1.10
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
7.71
LT Debt To Equity (MRQ)
7.64
Return on Investment (TTM)
-7.88
Return on Equity (TTM)
-7.69

Latest News

Latest News

Star stock-picker Cathie Wood buys the Zoom dip, invests over $56 million

Star investor Cathie Wood's funds scooped up $56.5 million worth of shares in Zoom Video Communications Inc, taking advantage of a 17% drop in the company's stock price on Tuesday after warning on slowing demand.

UPDATE 2-Teladoc shares tumble on membership growth worries

Teladoc Inc on Tuesday reported just a 1% rise in its membership - the lowest since the telehealth service provider went public in 2015 - as vaccine rollouts and easing COVID-19 related restrictions dampened demand for virtual healthcare.

Teladoc reports bigger quarterly loss

Teladoc Health Inc, the largest U.S. telehealth company, on Tuesday reported a bigger second-quarter loss due to higher stock-based compensation expense incurred related to its acquisition of Livongo Health.

Teladoc bets big on online medicine with $18.5 billion Livongo deal

Teladoc Health Inc <TDOC.N> has agreed to buy chronic care provider Livongo Health Inc <LVGO.O> in a deal valuing the company at $18.5 billion, betting on a boom in online care and consultations spurred by the coronavirus crisis.

Virtual care company Teladoc to buy Livongo in $18.5 bln deal

Teladoc Health said on Wednesday it would buy Livongo Health Inc in a deal valued at $18.5 billion, in a bid to create a leader in virtual care.

BRIEF-Teladoc Issued $1 Bln Of 1.25% Convertible Senior Notes Due 2027

* TELADOC HEALTH INC - ON MAY 19 ISSUED $1 BILLION AGGREGATE PRINCIPAL AMOUNT OF 1.25% CONVERTIBLE SENIOR NOTES DUE 2027 Source text: (https://bit.ly/2zSdKZr) Further company coverage:

BRIEF-Teladoc Health Prices Upsized Offering Of $850 Million Of Convertible Senior Notes Due 2027

* TELADOC HEALTH PRICES UPSIZED OFFERING OF $850 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027

BRIEF-Teladoc Health Announces Proposed Offering Of $800 Million Of Convertible Senior Notes Due 2027

* TELADOC HEALTH ANNOUNCES PROPOSED OFFERING OF $800 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027 Source text for Eikon: Further company coverage:

BRIEF-Teladoc Health Reports First-Quarter 2020 Results

* Q1 REVENUE $180.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $178.2 MILLION

Teladoc Health sees revenue above estimates on spike in demand due to coronavirus

Teladoc Health Inc <TDOC.N> said on Tuesday it expected its first-quarter revenue above estimates, as the telemedicine provider experiences an unprecedented surge in demand for its services due to the new coronavirus outbreak.

BRIEF-Teladoc Health Sees Q1 2020 Revenue $180 Mln To $181 Mln

* AS A RESULT OF GLOBAL OUTBREAK OF COVID-19, TELADOC HEALTH HAS EXPERIENCED AN UNPRECEDENTED SURGE IN DEMAND FOR ITS SERVICES

Teladoc Health says daily patient visits rose 50% in past week

Teladoc Health Inc on Friday said it experienced a 50% spike in patient visit volume over the prior week, in what the telehealth company called an "unprecedented daily visit volume" in the United States, as the coronavirus spreads globally.

BRIEF-Teladoc Health Forecasts FY 2020 Revenue Between $695 Million And $710 Million

* TELADOC HEALTH REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up